No internet connection — showing the saved version of the page.

Henry Schein Inc

USUSD
← to the screener

Henry Schein Inc (LSE:0L3C) — Medical Distribution. Number of exchanges where the company shares trade: 4. On this page — price and chart, dividends, top holders and share count history.

About the company

Website
henryschein.com
Investor relations
investor.henryschein.com/
Sector
Healthcare · Medical Distribution
Headquarters
MELVILLE, United States
Management
Andrea Albertini
  • Andrea Albertini · Chief Executive Officer, Global Distribution and Technology | Read more
  • Ronald N. South · Senior Vice President, Chief Financial Officer | Read more
  • Kelly Murphy · Senior Vice President and General Counsel | Read more
  • David Kochman · Senior Vice President, Chief Corporate Affairs Officer | Read more
  • Mark E. Mlotek · Executive Vice President, Chief Strategic Officer | Read more
  • Michael S. Ettinger · Executive Vice President and Chief Operating Officer | Read more
  • Christopher Pendergast · Senior Vice President and Chief Technology Officer | Read more
Latest reports
quarterly 2026 · 10-Q for the period ended 2026-03-28
Employees
25 000
Founded
1932
IPO
1995-11-03
Shares outstanding
111.45 M as of 2026-07-27
Free float
91.71 M
Market cap
9.39 B USD
Insiders
0.83%
Institutions
112.28%
Industry (SIC)
Wholesale-Medical, Dental & Hospital Equipment & Supplies
Legal form
XTIQ
ISIN
US8064071025
LEI
VGO3WGL8H45T73F4RR92
P/E
18.5
P/B
3.01
FCF
569 M USD
Debt
3.46 B USD
6.1 y of FCF
Earnings and FCF — for the 12 months to 27.06.2026 (the company's latest report).
Net income
403 M USD 12 mo.
For the 12 months to 27.06.2026 (4 quarters)
Revenue13.6 B USD
− Expenses12.9 B USD
Gross profit4.26 B USD
Net income403 M USD
History by quarter
RevenueExpenses
30.09.2023: Revenue 3.16 B · Expenses 2.96 B · Operating profit 200 M · Net income 137 M30.12.2023: Revenue 3.02 B · Expenses 2.98 B · Operating profit 39.0 M · Net income 18.0 M30.03.2024: Revenue 3.17 B · Expenses 3.02 B · Operating profit 150 M · Net income 93.0 M29.06.2024: Revenue 3.14 B · Expenses 2.98 B · Operating profit 159 M · Net income 104 M28.09.2024: Revenue 3.17 B · Expenses 3.02 B · Operating profit 157 M · Net income 99.0 M28.12.2024: Revenue 3.19 B · Expenses 3.04 B · Operating profit 155 M · Net income 94.0 M29.03.2025: Revenue 3.17 B · Expenses 2.99 B · Operating profit 175 M · Net income 110 M28.06.2025: Revenue 3.24 B · Expenses 3.09 B · Operating profit 151 M · Net income 86.0 M27.09.2025: Revenue 3.34 B · Expenses 3.18 B · Operating profit 164 M · Net income 101 M27.12.2025: Revenue 3.44 B · Expenses 3.27 B · Operating profit 163 M · Net income 101 M28.03.2026: Revenue 3.37 B · Expenses 3.19 B · Operating profit 182 M · Net income 107 M27.06.2026: Revenue 3.46 B · Expenses 3.29 B · Operating profit 171 M · Net income 94.0 M
09.202306.2026
Green above orange is profit (revenue − expenses); red below zero is a loss.
NAV
28.21 USD · P/NAV 3.01
Balance sheet date27.06.2026
Assets11.4 B USD
− Liabilities6.66 B USD
= Total equity3.82 B USD
− Non-controlling interests660 M USD
= NAV (equity of the company's shareholders)3.16 B USD
− Goodwill4.27 B USD
− Intangible assets965 M USD
= Tangible NAV−2.08 B USD
Shares111 916 222
NAV per share28.21 USD
Tangible NAV per share−18.59 USD
Share price (0L3C)84.8100 USD
P/NAV3.01
NAV history
Balance sheet dateNAVNAV per share
27.06.20263.16 B USD28.21 USD
28.03.20263.27 B USD28.54 USD
27.12.20253.25 B USD28.03 USD
27.09.20253.36 B USD28.35 USD
28.06.20253.45 B USD28.26 USD
29.03.20253.31 B USD27.08 USD
28.12.20243.39 B USD27.33 USD
28.09.20243.50 B USD27.99 USD
Description

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

advertisement

Exchanges and tickers

ExchangeTickerCurrencyPriceType
common stock
US USA StocksHSIC primaryUSD84.88 -1.80%common stock
LSE London Stock Exchange0L3C IOBUSD84.81 +0.00%common stock
MI Borsa Italiana (Milan)1HSIC secondaryEUR75 +0.00%common stock
VI Vienna Stock ExchangeHSIC secondaryEUR75 +1.35%common stock
depositary receipt
SA B3 Sao PauloH1SI34BRL—depositary receipt

Price

Hover / tap a day — open, close, high and low prices

Top holders

HolderStakeSharesReport date
Kohlberg Kravis Roberts…14.04%15.65 M2026-06-30
FMR, LLC6.78%7.55 M2026-06-30
Blackrock Inc.6.3%7.02 M2026-06-30
Artisan Partners Limited…5.8%6.47 M2026-06-30
Vanguard Capital Managem…5.69%6.35 M2026-06-30
JPMORGAN CHASE & CO3.9%4.34 M2026-06-30
State Street Corporation3.86%4.31 M2026-06-30
Vanguard Portfolio Manag…3.71%4.13 M2026-06-30
American Century Compani…3.1%3.46 M2026-06-30
Dimensional Fund Advisor…3.05%3.39 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.77%3.09 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.25%2.51 M2026-06-30
Invesco Exchange-Traded…2.15%2.4 M2026-08-31
VANGUARD INDEX FUNDS-Van…2%2.23 M2026-06-30
Fidelity Puritan Trust-F…1.81%2.02 M2026-06-30
J.P. Morgan Fleming Mutu…1.44%1.61 M2026-06-30
VANGUARD INDEX FUNDS-Van…1.27%1.41 M2026-06-30
American Century Capital…1.2%1.33 M2026-06-30
iShares Trust-iShares Co…1.17%1.31 M2026-07-31
AIM Sector Funds (Invesc…1.17%1.3 M2026-04-30
BERGMAN STANLEY M (Direc…≈0.58%643 1242026-05-26
BRESLAWSKI JAMES P (Pres…≈0.19%206 5422025-03-10
ALBERTINI ANDREA (Office…≈0.11%122 0922026-03-06
ETTINGER MICHAEL S. (Chi…≈0.1%112 4182026-03-17
LOWERY FREDERICK M. (Chi…≈0.09%95 1562026-03-06
SOUTH RONALD N. CPA (Chi…≈0.08%94 1462026-03-06
MLOTEK MARK E (Officer)≈0.08%89 0402026-03-06
POPECK THOMAS C (Officer…≈0.08%86 1822026-03-19
CONNETT BRADFORD C (Offi…≈0.06%62 6882025-03-19
SHEARES BRADLEY T (Direc…≈0.04%47 6232026-03-06